-
Alphabet's Eric Schmidt, Diane Greene To Leave Board This June
Wednesday, May 1, 2019 - 7:13am | 563Former Alphabet Inc (NASDAQ: GOOG)(NASDAQ: GOOGL) chairman and CEO Eric Schmidt will end an 18-year tenure on the board, the company announced Tuesday. After 18 years of board mtgs, I'm following coach Bill Campbell's legacy & helping the next generation of talent to serve. Thanks to...
-
Amgen Stock Falls After 'Boring' Q3 Beat
Thursday, October 26, 2017 - 9:49am | 449Reviewing Amgen, Inc. (NASDAQ: AMGN)'s third-quarter results, Cowen said the results were boring but very safe. The firm maintains its Buy rating and $209 price target for the shares of the company. At the time of writing, shares of Amgen were trading down 1.67 percent at $174.54. Analysts...
-
What To Make Of Alexion's New FDA Approval
Tuesday, October 24, 2017 - 8:10am | 421Shares of Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) were trading higher by more than 5 percent early Tuesday morning after the U.S. Food and Drug Administration approved its therapy called Soliris (eculizumab) for the treatment of adults with generalized myasthenia gravis (gMG). GMG represents a...
-
Google's Vision Of The Future Of A City On Display In Toronto
Wednesday, October 18, 2017 - 9:11am | 486What will a major city look like in the future? Anyone's guess was as good as the other, but we may now have an answer. Alphabet Inc (NASDAQ: GOOG) (NASDAQ: GOOGL) inked a deal with the city of Toronto to create a digital utopia, The Verge reported. Sidewalk Labs, a subsidiary of Alphabet, will...
-
Cowen Upgrades Bioverativ Shares To Outperform As TNT009 Heats Up
Monday, July 10, 2017 - 1:54pm | 379Cowen analyst Eric Schmidt thinks the experimental drug TNT009 could change the way investors think about Bioverativ Inc (NASDAQ: BIVV). Schmidt upgraded the company from Market Perform to Outperform and raised its price target from $47 to $80. Bioverative spun off from Biogen Inc (NASDAQ: BIIB)...
-
4 College Degrees Jack Ma Says Will Be Valuable In The Future
Thursday, June 29, 2017 - 4:02pm | 574Alibaba Group Holding Ltd (NYSE: BABA) founder Jack Ma recently discussed the ways the world is changing and the implications for the global economy in an interview with CNBC. Over the next 30 years, technology will evolve in a way that will make millions of jobs obsolete. While the transition will...
-
Kite Pharma A Top Pick Ahead Of Axi-Cel Launch
Tuesday, June 27, 2017 - 7:27am | 548Kite Pharma Inc (NASDAQ: KITE) is preparing to launch Axi-Cel, a chimeric antigen receptor T-cell therapy for non-Hodgkin’s lymphoma patients, later this year. Kite is pursuing an FDA label for patients with relapsed, aggressive and non-transplant eligible forms of the disease, a group of...
-
Investing In The Future Means Investing In Robotics Software And Services
Monday, June 26, 2017 - 7:28am | 531Loup Ventures is siding with the machines, concluding on Friday a series of notes analyzing the growth of robotics in the economy. “We believe a cultural shift is underway and robots are playing an increasingly crucial role in our everyday lives,” said analyst Andrew Murphy. Murphy...
-
So What If Robots Replace Puny Humans? Pro Chides Google Chief's Rosy View Of Automation
Tuesday, June 20, 2017 - 8:32am | 541Doug Clinton of Loup Ventures says Alphabet Inc (NASDAQ: GOOG) (NASDAQ: GOOGL) Chairman Eric Schmidt is wrong when he says automation won’t wipe out the majority of jobs now performed by inferior humans. “The five-year picture of automation isn’t going to result in mass job loss,...
-
For Rare Neural Diseases, Is Ovid Therapeutics The Right Team At The Right Time?
Tuesday, May 30, 2017 - 1:17pm | 390The Cowen Group has initiated coverage on Ovid Therapeutics Inc (NASDAQ: OVID) with an Outperform rating and $14.48 price target. It's Time To Tackle Orphan Neurological Disorders Until now, the biopharmaceutical industry has mostly ignored orphan neurological disorders due to the difficulty of...
-
Analyst: Kite Pharma's CAR-T Patient Death, Stock Selloff Is A Buying Opportunity
Monday, May 8, 2017 - 10:31am | 368For a biopharmaceutical company, there may be no worse news than the death of a patient receiving treatment during clinical testing. On Monday, shares of Kite Pharma Inc (NASDAQ: KITE) plummeted more than 12 percent after the company disclosed that a patient with brain cancer died following...
-
How Walt Mossberg Changed The Way We Think About Apple, Google And Others
Monday, April 10, 2017 - 7:26am | 961Walt Mossberg, a name synonymous with tech reporting, has decided to hang up his boots after a career spanning over 47 years. He made a name as a make-or-break reviewer of technology products, to whom many people looked before finalizing tech purchase decisions. Booting Into A Journalistic Career...
-
Should Alphabet's Larry Page Build A Relationship With President-Elect Trump?
Wednesday, January 18, 2017 - 3:26pm | 345Alphabet Inc (NASDAQ: GOOG) (NASDAQ: GOOGL)'s co-founder and CEO Larry Page needs to build a close relationship with President-elect Donald Trump, at least according to Adam Zuckerman, the founder of Fosterly. Speaking to CNBC, Zuckerman argued that Alphabet is one of the largest companies in the...
-
Who Is Alex Karp And Why Was He Given A Seat At Trump's Tech Summit Table?
Thursday, December 15, 2016 - 3:00pm | 393President-elect Donald Trump hosted some of the top technology leaders for a summit, and the guest list was a typical "who's who" of Silicon Valley with one exception. Names such as Apple Inc. (NASDAQ: AAPL)'s CEO Tim Cook, Amazon.com, Inc. (NASDAQ: AMZN)'s CEO Jeff Bezos, Alphabet Inc (NASDAQ:...
-
Alphabet Takes A Cue From Twitter, Moves Toward Diversifying Board
Thursday, June 30, 2016 - 2:20pm | 285Alphabet Inc (NASDAQ: GOOG) (NASDAQ: GOOGL) took a leaf out of Twitter Inc (NYSE: TWTR)'s playbook as it appointed its first African-American board member, naming Roger Ferguson, Jr. to its board of directors. A CNN Money report said Twitter appointed its first African-American board member, Debra...